A cross-market cost comparison of erlotinib versus pemetrexed for first-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Helge G Bischoff Stefan Walzer David F Heigener Javier de Castro Carpeño Christos Chouaid Alain Vergnenegre Mark Nuijten Francesco Grossi |
| Publication date | December 5, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |